Literature DB >> 24900069

Rituximab-Induced Lung Injury in a Case of NHL: Diagnosis and Follow-Up on FDG PET/CT.

Prathamesh Joshi1, Vikram Lele1, Tapan Saikia2.   

Abstract

Entities:  

Year:  2012        PMID： 24900069      PMCID： PMC4043035          DOI： 10.1007/s13139-012-0156-6

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  3 in total

1.  Interstitial pneumonitis related to rituximab therapy.

Authors:  Catherine Burton; Richard Kaczmarski; Riaz Jan-Mohamed
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 2.  Tolerability and safety of rituximab (MabThera).

Authors:  Eva Kimby
Journal:  Cancer Treat Rev       Date:  2005-07-28       Impact factor: 12.111

3.  Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment.

Authors:  J Bienvenu; R Chvetzoff; G Salles; C Balter; H Tilly; R Herbrecht; P Morel; P Lederlin; P Solal-Celigny; B Audhuy; B Christian; J Gabarre; O Casasnovas; G Marit; C Sebban; B Coiffier
Journal:  Hematol J       Date:  2001
  3 in total
  1 in total

1.  Hematologic neoplasms: interpreting lung findings in chest computed tomography.

Authors:  P Calvillo Batllés; J Carreres Polo; J Sanz Caballer; M Salavert Lletí; L Compte Torrero
Journal:  Radiologia       Date:  2015-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.